Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis. - Hoberger M; Zuber RL; Burkhard-Meier A; Di Gioia D; Jurinovic V; Völkl M; Güler SE; Albertsmeier M; Klein A; Dürr HR; Schmidt-Hegemann NS; Knösel T; et al. (Journal of cancer research and clinical oncology, 2026)